ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Degarelix Active In Phase II Trial In Prostate Cancer

October 29, 2004

Agency Approves Two Pairs Of Drugs and Diagnostic Tests

September 30, 2011

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

Clinical Trials Approved By NCI

October 31, 2003

NCI National Lab’s Budget to Grow Over Its $299.2 Million FY2013 Level

February 28, 2014

In Brief: Bresnick Directs Norris Cotton Cancer Center; FASEB Honors Kirschstein; Van Nevel’s 2th Year

February 5, 1993